La maladie de Parkinson au Canada (serveur d'exploration) - Checkpoint (Istex)

Index « Titre (en) » - entrée « mptp »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
mpsa < mptp < mri  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 26.
[0-20] [0 - 20][0 - 26][20-25][20-40]
Ident.Authors (with country if any)Title
000361 (2011) James B. Koprich [Canada] ; Susan H. Fox [Canada] ; Tom H. Johnston [Canada] ; Allan Goodman [États-Unis] ; Bertrand Le Bourdonnec [États-Unis] ; Roland E. Dolle [États-Unis] ; Robert N. Dehaven [États-Unis] ; Diane L. Dehaven-Hudkins [États-Unis] ; Patrick J. Little [États-Unis] ; Jonathan M. Brotchie [Canada]The selective mu‐opioid receptor antagonist adl5510 reduces levodopa‐induced dyskinesia without affecting antiparkinsonian action in mptp‐lesioned macaque model of Parkinson's disease
000623 (2010) Tom H. Johnston [Canada] ; Anne Van Der Meij [Pays-Bas] ; Jonathan M. Brotchie [Canada] ; Susan H. Fox [Canada]Effect of histamine H2 receptor antagonism on levodopa–induced dyskinesia in the MPTP‐macaque model of Parkinson's disease
000648 (2010) Pershia Samadi [Canada] ; Marc Morissette [Canada] ; Daniel Lévesque [Canada] ; Thérèse Di Paolo [Canada]BDNF levels are not related with levodopa‐induced dyskinesias in MPTP monkeys
000899 (2008) Pershia Samadi [Canada] ; Marc Morissette [Canada] ; Fréderic Calon [Canada] ; Abdallah Hadj Tahar [Canada] ; Mehdi Dridi [Canada] ; Nancy Belanger [Canada] ; Leonard T. Meltzer [États-Unis] ; Paul J. Bédard [Canada] ; Thérèse Di Paolo [Canada]Normalization of GABAA receptor specific binding in the substantia nigra reticulata and the prevention of L‐dopa‐induced dyskinesias in MPTP parkinsonian monkeys
000B27 (2006) Susan H. Fox [Canada] ; Anthony E. Lang [Canada] ; Jonathan M. Brotchie [Canada]Translation of nondopaminergic treatments for levodopa‐induced dyskinesia from MPTP‐lesioned nonhuman primates to phase IIa clinical studies: Keys to success and roads to failure
000B49 (2006) Marc Morissette [Canada] ; Mehdi Dridi [Canada] ; Frédéric Calon [Canada] ; Abdallah Hadj Tahar [Canada] ; Leonard T. Meltzer [États-Unis] ; Paul J. Bédard [Canada] ; Thérèse Di Paolo [Canada]Prevention of dyskinesia by an NMDA receptor antagonist in MPTP monkeys: Effect on adenosine A2A receptors
000B56 (2006) Naomi P. Visanji [Canada] ; Jordi Gomez-Ramirez [Canada] ; Tom H. Johnston [Canada] ; Donna Pires [Canada] ; Valerie Voon [Canada, États-Unis] ; Jonathan M. Brotchie [Canada] ; Susan H. Fox [Canada]Pharmacological characterization of psychosis‐like behavior in the MPTP‐lesioned nonhuman primate model of Parkinson's disease
000C62 (2005) Myreille D'Astous [Canada] ; Marc Morissette [Canada] ; Sophie Callier [Canada] ; Thérèse Di Paolo [Canada]Regulation of striatal preproenkephalin mRNA levels in MPTP‐lesioned mice treated with estradiol
000E78 (2003) Myreille D'Astous [Canada] ; Marc Morissette [Canada] ; Bastien Tanguay [Canada] ; Sophie Callier [Canada] ; Thérèse Di Paolo [Canada]Dehydroepiandrosterone (DHEA) such as 17β‐estradiol prevents MPTP‐induced dopamine depletion in mice
001023 (2001) Sophie Callier [Canada, France] ; Marc Morissette [Canada] ; Michelle Grandbois [Canada] ; Didier Pélaprat [France] ; Thérèse Di Paolo [Canada]Neuroprotective properties of 17β‐estradiol, progesterone, and raloxifene in MPTP C57Bl/6 mice
001066 (2001) Frédéric Calon [Canada] ; Nadia Lavertu [Canada] ; Anne-Marie Lemieux [Canada] ; Marc Morissette [Canada] ; Martin Goulet [Canada] ; Richard Grondin [Canada] ; Pierre J. Blanchet [Canada] ; Paul J. Bédard [Canada] ; Thérèse Di Paolo [Canada]Effect of MPTP‐induced denervation on basal ganglia GABAB receptors: Correlation with dopamine concentrations and dopamine transporter
001161 (2000) Sophie Callier [Canada, France] ; Marc Morissette [Canada] ; Michelle Grbois [Canada] ; Thérèse Di Paolo [Canada]Stereospecific prevention by 17β‐estradiol of MPTP‐induced dopamine depletion in mice
001267 (2000) Frédéric Calon ; Marc Morissette ; Martin Goulet ; Richard Grondin ; Pierre J. Blanchet ; Paul J. Bédard ; Thérèse Di Paolo125I-CGP 64213 Binding to GABAB Receptors in the Brain of Monkeys: Effect of MPTP and Dopaminomimetic Treatments
001372 (1999) Martin Goulet ; Marc Morissette ; Richard Grondin ; Pierre Falardeau ; Paul J. Bédard ; William Rostène [France] ; Thérèse Di PaoloNeurotensin receptors and dopamine transporters: Effects of MPTP lesioning and chronic dopaminergic treatments in monkeys
001A01 (1995) F. Calon [Canada] ; M. Goulet [Canada] ; P. J. Blanchet [Canada] ; J. C. Martel [Canada] ; M. F. Piercey [États-Unis] ; P. J. Be Dard [Canada] ; T. Di Paolo [Canada]Levodopa or D2 agonist induced dyskinesia in MPTP monkeys: correlation with changes in dopamine and GABAA, receptors in the striatopallidal complex
001B51 (1994) F. J. G. Vingerhoets [Canada] ; B. J. Snow [Canada] ; J. W. Tetrud [États-Unis] ; J. W. Langston [États-Unis] ; M. Schulzer [Canada] ; M. Calne [Canada]Positron emission tomographic evidence for progression of human MPTP‐induced dopaminergic lesions
001D16 (1993) Janice J. Pate [Canada] ; T. Kawamata [Canada] ; T. Yamada [Canada] ; E. G. Mcgeer [Canada] ; K. A. Hewitt [Canada] ; B. J. Snow [Canada] ; T. J. Ruth [Canada] ; D. B. Calne [Canada]Correlation of striatal fluorodopa uptake in the MPTP Monkey with dopaminergic indices
001E33 (1992) Baltazar Gomez-Mancilla [Canada] ; René Boucher [Canada] ; René Bédard [Canada]Effect of LY 171555 and CY 208‐243 on tremor suppression in the MPTP monkey model of parkinsonism
001F48 (1991) G. J. Tatton [Canada] ; C. E. Greenwood [Canada]Rescue of dying neurons: A new action for deprenyl in MPTP parkinsonism
002084 (1990) William G. Tatton [Canada] ; Mae M. Kwan [Canada] ; Mary C. Verrier [Canada] ; Nadine A. Seniuk [Canada] ; Elizabeth Theriault [Canada]MPTP produces reversible disappearance of tyrosine hydroxylase-containing retinal amacrine cells
002099 (1990) N. A. Seniuk [Canada] ; W. G. Tatton [Canada] ; C. E. Greenwood [Canada]Dose-dependent destruction of the coeruleus-cortical and nigral-striatal projections by MPTP

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Istex/Checkpoint
HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Checkpoint/Title.i -k "mptp" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Checkpoint/Title.i  \
                -Sk "mptp" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Istex
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Title.i
   |clé=    mptp
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022